Medroxyprogesterone acetate (oral)

Revision as of 18:14, 27 September 2011 by WikiBot (talk | contribs) (Protected "Medroxyprogesterone": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Synonyms / Brand Names: Medroxyprogesteronum, Medroxyprogesteron acetate, Medroxyprogesteron, Medroxiprogesteronum, Medroxiprogesterona, Medrossiprogesterone, Medroprogesterone Acetate, MAP, Hydroxymethylprogesterone, CBP-1011, Aragest, Aragest 5, Asconale, Clinofem, Clinovir, Colirest, DMPA, Depo-Clinovir, Depo-Prodasone, Depo-Progestin, Depo-Promone, Depot-Medroxyprogesterone acetate, Farlutal, Farlutin, G-Farlutal, Gestapuran, Hematrol, Hysron, Indivina, Lunelle, Lutopolar, Lutoral, Med-Pro, Meprate, Metigestrona, MPA Gyn 5, Nadigest, Nidaxin, Novo-Medrone, Oragest, Perlutex, Perlutex Leo, Prodasone, Progestalfa, Progevera, Proverone, Ralovera, Repromap, Repromix, Sirprogen, Sodelut G, Veramix

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

Vasomotor Symptoms / Vulvar and Vaginal Atrophy
Patients should be treated with the lowest effective dose. Generally women should be started at 0.3 mg/1.5 mg PREMPRO daily. Subsequent dosage adjustment may be made based upon the individual patient response. In patients where bleeding or spotting remains a problem, after appropriate evaluation, consideration should be given to changing the dose level. This dose should be periodically reassessed by the healthcare provider.

Postmenopausal Osteoporosis
Patients should be treated with the lowest effective dose. Generally women should be started at 0.3 mg/1.5 mg PREMPRO daily. Dosage may be adjusted depending on individual clinical and bone mineral density responses. This dose should be periodically reassessed by the healthcare provider. In patients where bleeding or spotting remains a problem, after appropriate evaluation, consideration should be given to changing the dose level. This dose should be periodically reassessed by the healthcare provider. PREMPHASE therapy consists of two separate tablets; one maroon 0.625 mg Premarin tablet taken daily on days 1 through 14 and one light-blue tablet, containing 0.625 mg conjugated estrogens and 5 mg of medroxyprogesterone acetate, taken on days 15 through 28.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Medroxyprogesterone acetate (oral)

Return to top

Publication Resources

Most Recent Articles on Medroxyprogesterone acetate (oral)

Review Articles on Medroxyprogesterone acetate (oral)

Articles on Medroxyprogesterone acetate (oral) in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Medroxyprogesterone acetate (oral)

Return to top

Trial Resources

Ongoing Trials with Medroxyprogesterone acetate (oral) at Clinical Trials.gov

Trial Results with Medroxyprogesterone acetate (oral)

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Medroxyprogesterone acetate (oral)

Cochrane Collaboration on Medroxyprogesterone acetate (oral)

Cost Effectiveness of Medroxyprogesterone acetate (oral)

Return to top

Media Resources

Powerpoint Slides on Medroxyprogesterone acetate (oral)

Images of Medroxyprogesterone acetate (oral)

Podcasts & MP3s on Medroxyprogesterone acetate (oral)

Videos on Medroxyprogesterone acetate (oral)

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Medroxyprogesterone acetate (oral)

Discussion Groups on Medroxyprogesterone acetate (oral)

Patient Handouts on Medroxyprogesterone acetate (oral)

Blogs on Medroxyprogesterone acetate (oral)

Medroxyprogesterone acetate (oral) in the News

Medroxyprogesterone acetate (oral) in the Marketplace

Return to top

International Resources

Medroxyprogesterone acetate (oral) en Español

Return to top


Adapted from the FDA Package Insert.